… The purpose of our study is to identify Parkinson’s disease subtypes based on how individuals are doing … to eight years after diagnosis. Some patients have few symptoms at this time, while others may have problems with … and Tocopherol Antioxidant Therapy of Parkinsonism and CALM-PD - Comparison of the Agonist Pramipexole with Levodopa on …

… (better known for the part it plays in depression) in dyskinesias, the disruptive movements brought on by …

… allosteric modulators to reduce the levodopa-induced dyskinesias associated with PD. - Pre-clinical work from …

… when those signals indicate medication wearing off or dyskinesia, for example. MJFF also has funded the Registry …

… symptoms), but increased side effects, such as weakness, dyskinesia, speech changes or walking problems. For some, …